Concepedia

Kathleen M. Mullane

KM

70

Publications

11.4K

Citations

40

H-Index

1995

Active since

Affiliations

University of Chicago(Current)

The University of Texas MD Anderson Cancer Center

Fred Hutch Cancer Center

University of Illinois Chicago

Merck & Co., Inc., Rahway, NJ, USA (United States)

Kathleen M. Mullane is an author at University of Chicago specializing in medicine, immunology, and antifungal agents.

Top concepts

MedicineImmunologyDrug ResistanceAntifungal AgentsHivInfection ControlClinical MicrobiologyHealthPharmacologyVaccination

Publications per year

1995–2024

70

Publications

70

Fidaxomicin versus Vancomycin for <i>Clostridium difficile</i> Infection

Thomas Louie, Mark A. Miller, Kathleen M. Mullane et al. · New England Journal of Medicine · 2011 · 1.6K citations · Full text

Remdesivir for 5 or 10 Days in Patients with Severe Covid-19

Jason D. Goldman, David Chien Lye, David S.C. Hui et al. · New England Journal of Medicine · 2020 · 1.4K citations · Full text

Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients With Moderate COVID-19

Christoph D. Spinner, Robert Gottlieb, Gerard J. Criner et al. · JAMA · 2020 · 1.3K citations · Full text

Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic-Cell Transplantation

Francisco M. Marty, Per Ljungman, Roy F. Chemaly et al. · New England Journal of Medicine · 2017 · 1.1K citations · Full text

Isavuconazole treatment for mucormycosis: a single-arm open-label trial and case-control analysis

Francisco M. Marty, Luis Ostrosky‐Zeichner, Oliver A. Cornely et al. · The Lancet Infectious Diseases · 2016 · 676 citations

Single-arm Open-label Trial, Antifungal Agent, Antifungal Agents +4

Rows per page

1–5 of 70